妊娠合并新型冠状病毒肺炎治愈17例临床分析

目的:探讨妊娠合并新型冠状病毒肺炎(COVID-19)的临床特点及治疗方法。方法:对武汉大学人民医院东院2020年1月31日至3月26日收治的妊娠合并COVID-19并痊愈出院的患者17例临床资料进行回顾性分析。结果:17例患者中轻型6例,普通型11例,无一例转为重症或危重症。发热10例,咳嗽6例,同时出现咳嗽、腹泻、气促及乏力等症状1例,无呼吸道症状4例。4例孕妇合并白细胞计数升高,10例出现淋巴细胞计数降低,11例出现淋巴细胞百分比降低,13例孕妇D-二聚体值升高。17例痊愈患者行抗病毒、抗感染及中成药物等对症支持治疗,10例使用小剂量糖皮质激素治疗,3例使用免疫调节剂,11例行低流量吸氧治疗。17例中6例患者(包含瘢痕子宫)因临产或先兆临产等原因经剖宫产术分娩,1例顺产,1例早孕自然流产,7例新生儿出生后查新型冠状病毒核酸均阴性。9例患者出院后继续妊娠。17例患者经治疗后各项指标均好转,符合出院标准。结论:早发现、早治疗、适时终止妊娠对改善妊娠合并COVID-19的预后有一定效果,轻型或普通型COVID-19孕妇无终止妊娠的其他医学指征,可在严密监测下继续妊娠,COVID-19病毒及治疗药物对胎儿的影响尚待进一步研究。     

无症状伴肺部影像学改变的新型冠状病毒肺炎孕妇一例

本文为孕晚期无症状新型冠状病毒肺炎(COVID-19)一例报告,孕妇分娩前有胸部CT典型肺炎表现,母儿结局良好。患者孕37周+3因"新型冠状病毒核酸检测阳性7 h余"于2020年2月12日由外院转入宜春市人民医院。患者孕期定期产前检查无异常,入院前无任何不适。患者的丈夫和婆婆分别于患者入院前8 d和当日确诊为COVID-19。入院第2天胸部CT示右肺下叶见斑片状模糊影,胎心监测发现基线微小变异,考虑胎儿窘迫可能,在做好防护的情况下行,急诊剖宫产娩出一活女婴。术后产妇及新生儿分别送至隔离病区进行单间隔离观察治疗。参与剖宫产手术相关医护人员术后均采取单间隔离。术后给予患者抗病毒和抗感染治疗,患者恢复良好,仍无发热、乏力、咳嗽等症状,术后3和5 d咽拭子新型冠状病毒核酸检测均为阴性,术后4 d胸部CT提示右肺下叶炎症、术后7 d复查示右肺下叶炎症稍吸收。新生儿分别于出生当天、4日龄和7日龄取外周血和咽拭子标本行新型冠状病毒核酸检测,结果均为阴性。母女术后9 d顺利出院。参与手术的相关医护人员术后7和14 d咽拭子新型冠状病毒核酸检测结果均阴性。     

孕晚期合并无症状新型冠状病毒感染一例

本文为孕晚期无症状新型冠状病毒感染一例报告,母儿结局良好。患者孕38周因"新型冠状病毒核酸检测阳性1 d"于2020年2月11日入住合肥市第二人民医院。患者孕期定期产前检查且均未见异常。因其丈夫及姐姐分别于患者入院前14和7 d先后确诊为新型冠状病毒肺炎(COVID-19),患者入院前咽拭子新型冠状病毒核酸检测阳性。患者入院前无任何不适。入院第3天,胸部CT示两肺未见异常,仅两侧少量胸腔积液;患者出现不规律宫缩,急诊剖宫产娩出一活女婴。未行羊水、脐带血、胎盘等病原学检查。术后未行母乳喂养,患者与新生儿分室隔离,参与剖宫产手术相关医护人员术后均采取单间隔离。新生儿于出生当天、1日龄分别取外周血、鼻咽拭子,9日龄分别取鼻咽拭子、肛拭子进行新型冠状病毒核酸检测,结果均为阴性。患者术后恢复情况良好,生命体征平稳,术后8 d胸部CT提示两侧少量胸腔积液,术后11和12 d复测咽拭子新型冠状病毒核酸结果均为阴性。母女于术后14 d顺利出院。参与手术的相关医护人员术后14 d咽拭子新型冠状病毒核酸检测结果均阴性。     

妊娠不同时期感染新型冠状病毒肺炎的随访研究

目的通过研究不同妊娠时期感染新型冠状病毒患者的妊娠结局,分析新型冠状病毒对孕妇及新生儿出生后近期体格生长发育的影响,了解武汉地区COVID-19孕产妇及新生儿在后期的随访情况及需要解决的问题。方法收集2020年1月30日至2020年4月30日在武汉大学人民医院住院治疗的妊娠合并新型冠状病毒肺炎确诊病例共25例,总结早期(5例)、中期(5例)、晚期妊娠(15例)患者感染SRAS-CoV-2的临床特征、治疗、妊娠结局以及母婴随访等。结果5例早期妊娠合并COVID-19患者中,4例治愈出院后选择放弃妊娠,1例住院期间生化妊娠。5例中期妊娠合并COVID-19的患者中,活产儿4例,引产1例(胎儿心脏多发异常,双肾多发囊性病变,鼻骨偏短,羊水少)。新生儿出生后首次SRAS-CoV-2核酸鼻咽拭纸检测阴性。2020年10月随访结果显示,新生儿身长、体重及神经系统发育未见明显异常,1例患儿溶血性黄疸,1例患儿心脏室间隔缺损,卵圆孔未闭,二尖瓣反流,拟近期手术。15例晚期妊娠合并COVID-19患者中,早产3例,足月产12例。新生儿出生后首次SRAS-CoV-2核酸鼻咽拭纸检测阴性,2020年10月随访结果显示,新生儿身长、体重未见异常,1例小肠坏死伴高胆红素血症,4例细菌性肺炎,2例患儿肌张力过高。选取6例患者的胎盘行SARS-CoV-2检测均为阴性,病理检查中有1例胎盘胎膜未见明显异常,1例胎盘局灶可见散在的中性粒细胞,4例胎盘表现为急性绒毛膜炎(母体反应1级)。结论早期妊娠感染新型冠状病毒患者治愈后均选择终止妊娠。中、晚孕期感染新型冠状病毒肺炎孕妇分娩的新生儿近期随访身长、体重未发现明显异常,但仍有流产、胎儿畸形、绒毛膜炎、新生儿细菌性肺炎、肌张力增高等。因此,孕期新型冠状病毒感染可能导致不良围产期结局,这有待更大样本的流行病学研究调查证实。     

围产期新型冠状病毒感染一例

本文报告1例围产期新型冠状病毒感染患者的诊治经过及围产结局。孕妇孕37周+2因"严重肝功能异常"行急诊剖宫产娩出一活男婴。术后第2天产妇出现发热,经咽拭子核酸检测确诊新型冠状病毒感染。经隔离及对症支持治疗12 d,连续2次核酸检测阴性痊愈出院。患者血、尿、乳汁及新生儿咽拭子均未检测到新型冠状病毒核酸。新生儿心肌酶升高,隔离14 d后痊愈出院。     

妊娠晚期合并新冠肺炎的围生期结局

目的:探讨妊娠晚期合并新型冠状病毒肺炎患者的临床特点、治疗及母儿结局。方法:回顾分析2020年1月1日至2020年2月12日华中科技大学同济医学院附属同济医院收治的23例妊娠晚期合并新冠肺炎患者的临床资料,分析其流行病学特点、临床特点、治疗和母儿结局。结局随访至2月18日。结果:23例患者均无华南海鲜市场接触史,均为武汉疫区居住史。患者平均年龄(32.34±6.21)岁(23～42岁),均为足月妊娠,平均孕周为39周(37～41~(+2)周)。临床表现中有发热13例(56.52%)、咳嗽6例(26.09%)、呼吸急促1例(4.35%)和腹泻2例(8.70%)。18例患者行剖宫产和5例患者经阴分娩终止妊娠,平均39~(+2)周,孕妇和新生儿的预后良好。对其中9例新生儿进行新型冠状病毒(SARS-CoV-2)咽试纸核酸检测,36h后发现1例新生儿感染SARS-CoV-2。结论:产妇为新型冠状病毒肺炎的易感人群,对于足月或肺部病变进展迅速患者,建议及时终止妊娠。本例研究发现,妊娠晚期合并新冠肺炎及时终止妊娠者母婴结局良好,远期结局及是否存在母婴垂直传播有待进一步研究。     

围妊娠期接种新型冠状病毒肺炎疫苗对妊娠结局的影响

目的：探讨围妊娠期接种新型冠状病毒肺炎（coronavirus disease 2019,COVID-19）疫苗对妊娠结局的影响,为围妊娠期女性接种COVID-19疫苗的免疫策略提供参考依据。方法：回顾性分析2021年5月—2022年11月于芜湖市第一人民医院及医联体医院住院分娩或流产、早产的1 987例孕产妇的临床和妊娠结局资料,根据是否接种COVID-19疫苗分为接种疫苗组（n=1 346）和未接种疫苗组（n=641）,分析2组临床资料、妊娠结局、孕产妇合并症/并发症及新生儿结局。结果：1 346例孕产妇接种灭活疫苗913例（67.83%）、重组亚单位疫苗417例（30.98%）及腺病毒载体疫苗16例（1.19%）。接种疫苗组经产妇比例高于未接种疫苗组（60.18%vs. 35.22%,P<0.001）,妊娠期高血压疾病发生率低于未接种疫苗组（4.61%vs. 7.49%,P=0.009）。2组妊娠期糖尿病、妊娠期贫血、胎膜早破、羊水污染、产后出血、产褥期感染、早产儿、新生儿畸形、低出生体质量儿、入住新生儿重症监护病房、新生儿分娩后5 min Apgar评分≤7分的发生率比较...     

新型冠状病毒感染疫情下的妊娠管理策略

2019年12月,湖北省武汉市陆续发现多例感染新型冠状病毒肺炎患者[1],随后该新型冠状病毒感染逐渐蔓延至全国以及其他国家,世界卫生组织(WHO)将其命名为2019冠状病毒病(corona virus disease 2019,COVID-19)。该病传染性强,已纳入《中华人民共和国传染病防治法》规定的乙类传染病,并按甲类传染病管理。人群对COVID-19普遍易感,孕妇也不例外.且由于妊娠引起心肺负荷增加,孕妇感染后病情可能会更加危重而导致严重的不良妊娠结局,甚至引起孕产妇及围产儿死亡。在此疫情下,产科医生不仅要加强自我防护,也要加强对COVID-19相关知识的学习,并将此运用到产科临床实践中,熟悉疑似和确诊的COVID-19孕妇管理流程,严格按照多学科管理共同治疗COVID-19孕妇。     

妊娠期接种COVID-19疫苗对妊娠结局影响的研究进展

新型冠状病毒肺炎（corona virus disease 2019,COVID-19）是一种以呼吸道症状为主的急性传染病,迄今尚无特效的治疗方法。除一般的预防措施外,接种疫苗是一种安全、有效的措施。然而,由于孕产妇及哺乳期妇女的群体特殊性,对COVID-19疫苗的安全性和有效性存在疑虑,导致COVID-19疫苗的接种率低,相关数据相对缺乏。但随着妊娠期发生的一系列生理变化,孕妇更容易感染新型冠状病毒,不良妊娠结局发生风险也随之增加。因此,总结COVID-19疫苗在孕产妇中的安全性及有效性证据十分必要,为后续开展相关研究以及COVID-19疫苗的安全性评价提供参考。     

妊娠晚期危重型新型冠状病毒肺炎一例

本文报告一例妊娠晚期合并新型冠状病毒肺炎(COVID-19)危重型孕妇。患者32岁,孕35周+2因"咽痛4 d,发热3 h"入院。入院前曾至湖北孝感应城,回家隔离期间发病。入院后病情进展迅速,7 h后出现左侧胸背部疼痛、气促、头晕,迅即出现呼吸衰竭、感染性休克。考虑病情严重,且有2次剖宫产史,行紧急子宫下段剖宫产术。术前血气分析示呼吸衰竭、呼吸性酸中毒合并代谢性酸中毒。术中娩出一男婴,2700 g,1 min Apgar评分1分(心率20次/min),经复苏抢救,5和10 min评分均为1分,家属放弃抢救后死亡。产妇术后气管插管呼吸机维持,同时给予其他支持治疗。入院时的新型冠状病毒核酸检测结果于分娩后报告为阳性,遂转入定点医院治疗。患者术后26 d体外膜肺氧合脱机成功,术后36 d脱离呼吸机,进入康复阶段。     

孕产妇合并甲型H1N1流感对母儿结局的影响

目的 探讨孕产妇合并甲型H1N1流感(简称甲流)对母儿结局的影响及产科处理.方法 收集2009年11月7日至2009年12月15日中国医科大学附属盛京医院收治的19例合并甲流的孕产妇资料,回顾性分析甲流对母儿的影响. 结果 19例患者中,产褥期妇女3例,占15.8%,均为轻症,愈后良好.孕期患者16例,占84.2%,其中早期妊娠2例(12.5%),中期妊娠7例(43.8%),晚期妊娠7例(43.8%).16例孕期患者按病情严重程度分,轻症6例(37.5%),重症2例(12.5%),危重症8例(50.0%).2例早期妊娠患者均为轻症,甲流治愈后选择人工流产;中期妊娠的4例轻症患者甲流治愈后足月分娩,3例重症及危重症患者中1例甲流治愈后足月分娩,1例孕27周胎死宫内和1例孕23周因孕妇发生严重并发症,均行剖宫取胎术,后者胎儿娩出后死亡;妊娠晚期的7例均为重症及危重症患者,均行急诊剖宫产术终止妊娠,2例胎儿孕晚期胎死宫内,余5例存活,包括4例早产儿和1例足月儿.行急诊剖宫产手术的全部9例(56.3%,9/16)重症及危重症孕妇中,活产新生儿6例,存活的5例均未感染甲流;2例孕产妇术后死亡(10.5%,2/19). 结论妊娠晚期孕妇感染甲流极易发展为重症及危重症,及时终止妊娠是挽救母儿生命又使新生儿避免甲流病毒感染的有效方法之一.     

Clinical and obstetric characteristics of pregnant women with Covid-19: A case series study on 26 patients

ObjectiveTo evaluate the clinical characteristics and outcomes of pregnant women with Covid-19.Materials and methodsThis case series study was performed to investigate demographic, clinical and obstetric characteristics of 26 pregnant women with COVID-19 referring to a university hospital of Kashan during the epidemic of COVID-19 (March to May 2020).ResultsThe mean gestational age of the patients at admission and delivery was 31.8 ± 5.2 and 36.3 ± 3.4 weeks, respectively. The most common symptoms were fever (96.2%) followed by dyspnea and cough (30.8%). The findings of lung CT scan showed abnormalities confirming the pneumonia in 22 patients (84.6%). Cesarean section was performed in 69.2% of the mothers. The most common maternal–fetal outcome was preterm delivery (38%). Two mothers were transferred to the ICU due to deterioration in clinical condition and they underwent mechanical ventilation without any maternal death. The most common neonatal outcomes were prematurity (38%) and low birth weight (34.6%). No cases of confirmed COVID-19 were observed in the neonates.ConclusionClinical manifestations and laboratory and radiographic findings in pregnant women with COVID-19 are similar to the general population. Common outcomes of pregnancy and delivery in mothers included increased rate of preterm delivery and cesarean section. The most prevalent neonatal outcomes included prematurity and LBW. Careful monitoring of pregnant women with COVID-19 is recommended.     

Pregnancy and delivery outcomes in the women who have received adenomyomectomy: Performed by a single surgeon by a uniform surgical technique

ObjectiveAlthough adenomyomectomy for fertility-sparing is an expanding procedure worldwide, there is no guideline or consensus about how to manage the pregnant women who have previously received conservative surgery for adenomyosis. The aim of this study is to evaluate antenatal care and delivery outcomes in pregnant women after adenomyomectomy.Materials and methodsBetween May 2011 and May 2019, the medical record was reviewed in all delivery of pregnant women received adenomyomectomy performed by a single surgeon by a uniform surgical technique. The evaluating parameters consisted of antenatal care outcomes, delivery outcomes, intrapartum outcome, and neonatal outcomes.ResultsTwenty-two patients were evaluated to monitor pregnancy and delivery outcomes after the adenomyomectomy. Mean age of delivery was 37.0 years old (SD = 3.1, range 32–45, median 37). All were delivered by cesarean section. Mean gestational age was 36.2 weeks (SD = 3.6, range 27.4–39.4, median 37.3). The mean birth weight was 2560.9 g (SD = 771.8, range 1100–3920, median 2550) and the number of preterm births admitted for prematurity care was seven (31.8%, 7/22). Placental abnormality was found in the four cases, which included two placenta accreta and two previa. However, there were no cases of hysterectomy or intervention. We identified one case of uterine rupture during pregnancy (4.5%, 1/22) at 27 weeks of gestation. Except for preterm birth, adverse neonatal outcomes were not found in this study.ConclusionDelivery of pregnant women who received adenomyomectomy can obtain safe perinatal outcomes under close monitoring of preterm labor and surveillance of catastrophic pregnancy related complications.     

Coxsackievirus-positive cervices in women with febrile illnesses during the third trimester in pregnancy

Coxsackievirus B5 infection was demonstrated in five of seven third-trimester pregnant women with undifferentiated febrile illnesses or aseptic meningitis. Coxsackievirus B5 was recovered from the cervix and throat in four women and from the rectum in three. No obvious illnesses were evident in the babies. These findings suggest that previously unrecognized cervical enterovirus carriage or infection is common in infected pregnant women in the last trimester and that subsequent neonatal infection at delivery may result.     

妊娠合并慢性粒细胞性白血病患者的临床处理特点及妊娠结局分析

目的 探讨妊娠合并慢性粒细胞性白血病(CML)患者的临床处理特点及妊娠结局.方法 1980年6月至2010年2月北京大学人民医院产科共收治妊娠合并CML 16例,采用回顾性分析的方法对妊娠合并CML患者的孕期特点、临床处理及妊娠结局进行分析.结果 (1)孕期临床处理及妊娠结局:16例妊娠合并CML患者中,9例经应用羟基脲或甲磺酸伊马替尼控制病情后,在孕早、中期终止妊娠;该9例患者就诊时平均孕周为7周(5～13周),终止妊娠前、后对症输入红细胞纠正严重贫血,应用抗生素预防感染,未发生相关并发症.另7例妊娠至孕晚期分娩患者中,3例为孕前诊断CML,4例为孕期诊断CML.7例分娩患者就诊时平均孕周为36周(27～40周+2),孕期3例患者服用羟基脲,其中1例在用药过程中受孕,孕期仍继续用药.1例患者在孕40周入院后行白细胞单采术2次.1例行血小板单采术1次.3例未行任何治疗.孕期并发重度子痫前期3例(3/7),其中2例口服羟基脲治疗.7例患者平均分娩孕周为38周(33周+4～41周),其中早产2例.分娩方式为剖宫产2例,阴道顺产3例,产钳助娩2例.有2例阴道顺产者发生产后出血,产后24 h出血量达1500～1800 ml,并引起继发性DIC.7例患者共分娩新生儿7例,新生儿平均出生体质量2469 g(1820～2810 g).早产儿2例,低出生体质量儿2例,1例存在先天畸形,2例血常规检查异常.(2)产后治疗及预后随访:9例孕早、中期终止妊娠的患者中,失访4例;死亡1例,其病程3年;余4例随访5～72个月均存活,其中1例行骨髓移植术后治愈,2例坚持服用甲磺酸伊马替尼,1例服用羟基脲治疗.7例分娩的患者中,2例失访;2例死亡;3例存活.7例新生儿中2例失访,余5例随访4个月～9年,均生长发育正常.结论 妊娠合并CML并非为终止妊娠的绝对指征.孕期在严密监测病情变化的同时,选用相应的药物和(或)白细胞单采术治疗,监测妊娠并发症的发生,可以获得较好的妊娠结局.CML本身和孕期治疗会对母儿产生一定的影响,因此,需要在有条件的综合医院进行治疗和管理.     

Cerebrospinal fluid analysis of pregnant women at early stages of COVID-19

ObjectiveTo determine the presence or absence of SARS-CoV-2 in the cerebrospinal fluid of pregnant women at early stages of COVID-19.Materials and methodsWe conducted a prospective observational study with pregnant women undergoing cesarean section and real-time polymerase chain reaction to SARS-CoV-2 was performed in the cerebrospinal fluid in the early stages of COVID-19.ResultsFourteen pregnant women, whose COVID-19 symptoms started between four to 18 days prior to delivery, were included. Eleven of the women reported anosmia, dysgeusia, and headaches and there were two fatal cases. SARS-Cov-2 was not present in the cerebrospinal fluid of these COVID-19 patients with early neurological symptoms, even in severe cases.ConclusionOur study suggests that peripheric cell damage and parainfectious phenomena may predominate over direct central nervous system injury in the pathophysiology of COVID-19 related early neurological symptoms on pregnant women.